Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0971
-0.0006 (-0.59%)
At close: Nov 28, 2025
Oncotelic Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 0.41 | 0.09 | 0.17 | 0.24 | 0.57 | 0.47 | Upgrade |
Cash & Short-Term Investments | 0.41 | 0.09 | 0.17 | 0.24 | 0.57 | 0.47 | Upgrade |
Cash Growth | 174.46% | -49.46% | -29.43% | -57.55% | 19.99% | 478.33% | Upgrade |
Accounts Receivable | - | - | 0.02 | - | - | 0.02 | Upgrade |
Other Receivables | 0 | 0.02 | - | 0.02 | 0.02 | - | Upgrade |
Receivables | 0 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade |
Prepaid Expenses | 1.18 | 0.01 | 0.06 | 0.02 | 0.02 | 0.1 | Upgrade |
Restricted Cash | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade |
Total Current Assets | 1.61 | 0.13 | 0.27 | 0.3 | 0.63 | 0.62 | Upgrade |
Property, Plant & Equipment | - | - | - | - | - | 0.01 | Upgrade |
Long-Term Investments | 22.65 | 22.65 | 22.65 | 22.64 | - | - | Upgrade |
Goodwill | 2.79 | 2.79 | 5.99 | 12.07 | 21.06 | 21.06 | Upgrade |
Other Intangible Assets | - | - | - | - | 0.82 | 1.97 | Upgrade |
Long-Term Deferred Charges | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | - | Upgrade |
Total Assets | 28.16 | 26.68 | 30.01 | 36.12 | 23.61 | 23.66 | Upgrade |
Accounts Payable | 1.69 | 1.69 | 1.66 | 1.74 | 1.93 | 1.94 | Upgrade |
Accrued Expenses | 1.22 | 1.09 | 1.12 | 1.11 | 1.57 | 1.19 | Upgrade |
Short-Term Debt | 13.87 | 13.09 | 10.68 | 11.26 | 8.99 | 4.65 | Upgrade |
Other Current Liabilities | 3.3 | 3.33 | 3.05 | 2.82 | 2.97 | 3.4 | Upgrade |
Total Current Liabilities | 20.08 | 19.2 | 16.5 | 16.92 | 15.45 | 11.18 | Upgrade |
Long-Term Debt | - | - | 1.9 | - | - | - | Upgrade |
Total Liabilities | 20.08 | 19.2 | 18.4 | 16.92 | 15.45 | 11.18 | Upgrade |
Common Stock | 4.39 | 4.07 | 3.99 | 3.92 | 3.75 | 0.91 | Upgrade |
Additional Paid-In Capital | 43.77 | 42.22 | 41.66 | 41.42 | 35.22 | 32.49 | Upgrade |
Retained Earnings | -39.11 | -38.04 | -33.52 | -25.93 | -31.02 | -21.63 | Upgrade |
Total Common Equity | 9.05 | 8.25 | 12.13 | 19.41 | 7.96 | 11.77 | Upgrade |
Minority Interest | -0.97 | -0.77 | -0.52 | -0.22 | 0.2 | 0.71 | Upgrade |
Shareholders' Equity | 8.08 | 7.48 | 11.61 | 19.19 | 8.16 | 12.48 | Upgrade |
Total Liabilities & Equity | 28.16 | 26.68 | 30.01 | 36.12 | 23.61 | 23.66 | Upgrade |
Total Debt | 13.87 | 13.09 | 12.57 | 11.26 | 8.99 | 4.65 | Upgrade |
Net Cash (Debt) | -13.46 | -13 | -12.4 | -11.02 | -8.42 | -4.18 | Upgrade |
Net Cash Per Share | -0.03 | -0.03 | -0.03 | -0.02 | -0.03 | -0.05 | Upgrade |
Filing Date Shares Outstanding | 440.78 | 408.29 | 399.68 | 392.87 | 378.63 | 91.26 | Upgrade |
Total Common Shares Outstanding | 439.45 | 407.29 | 399.18 | 391.85 | 375.29 | 90.6 | Upgrade |
Working Capital | -18.47 | -19.07 | -16.23 | -16.62 | -14.83 | -10.57 | Upgrade |
Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.05 | 0.02 | 0.13 | Upgrade |
Tangible Book Value | 6.26 | 5.46 | 6.14 | 7.34 | -13.93 | -11.27 | Upgrade |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.02 | 0.02 | -0.04 | -0.12 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.